Bristol-Myers Squibb (BMY) reported Q4 non-GAAP earnings Thursday of $1.26 per diluted share, down from $1.67 a year earlier.

Analysts surveyed by FactSet expected $1.23.

Revenue for the quarter ended Dec. 31 was $12.50 billion, compared with $12.34 billion a year earlier.

Analysts surveyed by FactSet expected $12.28 billion.

For 2026, the company expects adjusted EPS of $6.05 to $6.35 on revenue of $46 billion to $47.50 billion. Analysts are looking for $6.02 and $44.18 billion, respectively.

Bristol-Myers shares were up 4.4% in recent premarket activity.